SCHEMBL4638533

SCHEMBL4638533

Cc1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NC1Cc2ccccc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
SFRP1 Q8N474 5/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
USP30 Q70CQ3 1/20 0.44
APOB P04114 1/20 0.43
MTTP P55157 1/20 0.43
WNT3 P56703 2/20 0.43
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
BRD4 O60885 3/20 0.42
BRD2 P25440 3/20 0.42
BRD3 Q15059 3/20 0.42
ALDH1A1 P00352 2/20 0.40
CA1 P00915 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638257 0.91 SFRP1 (0.54) SFRP1MEN1KMT2AWNT3BRD4
SCHEMBL4637122 0.90 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6102391 0.88 LMNA (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6102553 0.81 BRD4 (0.47) SFRP1USP30WNT3BRD4BRD2
SCHEMBL4617124 0.81 SFRP1 (0.59) SFRP1USP30WNT3BRD4BRD2
SCHEMBL4617350 0.80 USP30 (0.43) SFRP1USP30WNT3BRD4BRD2
SCHEMBL4617354 0.80 USP30 (0.43) SFRP1USP30WNT3BRD4BRD2
SCHEMBL4617347 0.80 USP30 (0.43) SFRP1USP30WNT3BRD4BRD2
SCHEMBL4619410 0.80 SFRP1 (0.57) SFRP1WNT3BRD4BRD2BRD3
SCHEMBL4618526 0.79 SFRP1 (0.61) SFRP1USP30WNT3ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 PSEN1 126/4885PSEN2 516/4885APH1B 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.